We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-4.84%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
AUM
$382M
AUM Growth
-$12.2M
Cap. Flow
+$8.02M
Cap. Flow %
2.1%
Top 10 Hldgs %
22.97%
Holding
364
New
54
Increased
102
Reduced
61
Closed
14

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$6.89M
2
HSY icon
Hershey
HSY
+$5.15M
3
ORCL icon
Oracle
ORCL
+$5.04M
4
TGT icon
Target
TGT
+$4.76M
5
QCOM icon
Qualcomm
QCOM
+$4.69M

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$6.02M
2
CMCSA icon
Comcast
CMCSA
+$5.69M
3
CSCO icon
Cisco
CSCO
+$5.46M
4
DHR icon
Danaher
DHR
+$5.43M
5
PFE icon
Pfizer
PFE
+$2.28M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Healthcare 12.6%
3 Financials 9.81%
4 Industrials 9.47%
5 Consumer Staples 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGTX icon
326
TG Therapeutics
TGTX
$7.64B
$1.06K ﹤0.01%
127
GLD icon
327
SPDR Gold Trust
GLD
$138B
$1.03K ﹤0.01%
6
NIO icon
328
NIO
NIO
$11.7B
$904 ﹤0.01%
100
BHF icon
329
Brighthouse Financial
BHF
$3.55B
$783 ﹤0.01%
16
SPRE icon
330
SP Funds S&P Global REIT Sharia ETF
SPRE
$223M
$689 ﹤0.01%
+39
New +$748
FSR
331
DELISTED
Fisker Inc.
FSR
$642 ﹤0.01%
100
POST icon
332
Post Holdings
POST
$4.11B
$600 ﹤0.01%
7
AIG icon
333
American International
AIG
$42.1B
$545 ﹤0.01%
9
NUE icon
334
Nucor
NUE
$62.6B
$502 ﹤0.01%
3
-24
-89% -$3.97K
ATHE
335
Alterity Therapeutics
ATHE
$79.2M
$496 ﹤0.01%
200
MTTR
336
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$434 ﹤0.01%
200
PHO icon
337
Invesco Water Resources ETF
PHO
$2.08B
$425 ﹤0.01%
8
BRBR icon
338
BellRing Brands
BRBR
$1.47B
$330 ﹤0.01%
8
GTHX
339
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$305 ﹤0.01%
212
DAL icon
340
Delta Air Lines
DAL
$61.3B
$296 ﹤0.01%
8
AMBP.WS
341
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$295 ﹤0.01%
+2,952
New +$346
CLOV icon
342
Clover Health Investments
CLOV
$2.18B
$270 ﹤0.01%
250
PSFE icon
343
Paysafe
PSFE
$412M
$252 ﹤0.01%
21
WATT icon
344
Energous
WATT
$98.4M
$229 ﹤0.01%
5
COMP icon
345
Compass
COMP
$9.59B
$203 ﹤0.01%
70
FATE icon
346
Fate Therapeutics
FATE
$303M
$129 ﹤0.01%
61
AAL icon
347
American Airlines Group
AAL
$11B
$51 ﹤0.01%
4
DAVA icon
348
Endava
DAVA
$157M
0
AXDX
349
DELISTED
Accelerate Diagnostics
AXDX
$23 ﹤0.01%
4
-1
-20% -$7
ACB
350
Aurora Cannabis
ACB
$180M
$7 ﹤0.01%
1

Similar funds

Providence Capital Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Providence Capital Advisors held 364 positions worth $382M, down 3.1% from $394M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Providence Capital Advisors's Q3 2023 filing shows 54 new, 102 increased, 61 reduced and 14 closed positions. Its largest new stake was Hershey: 23,010 shares worth $4.6M. The largest sale was Applied Materials, an estimated $6.02M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Providence Capital Advisors's largest Q3 2023 buy was Hershey: 23,010 shares worth $4.6M.
  • Providence Capital Advisors added most to Abbott in Q3 2023, an estimated $6.89M increase.
  • Providence Capital Advisors's biggest Q3 2023 reduction was Applied Materials, cutting an estimated $6.02M.
  • Providence Capital Advisors fully exited JPMorgan Equity Premium Income ETF in Q3 2023, selling an estimated $124K.
  • Providence Capital Advisors's ten largest holdings make up 23% of its $382M portfolio in Q3 2023.
  • Providence Capital Advisors opened 54 new positions and closed 14 in Q3 2023.
  • Providence Capital Advisors's portfolio value fell 3.1% quarter-over-quarter to $382M.

Based on Providence Capital Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.